Acrux Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
25
- Stock Symbol
-
ACR
- Investments
-
1
Acrux General Information
Description
Acrux Ltd is a specialty pharma company that develops and commercialises specialty and generic, transdermal and topical pharmaceuticals. Its products include creams, gels, and sprays formulated for topical and transdermal drug delivery. The company operates as a single operating segment, which derives revenue from developing and commercialising pharmaceutical products. Its geographical segments are Australia, Europe and other countries, and the United States. The majority of revenue is derived from Australia.
Contact Information
Website
www.acrux.com.auCorporate Office
- 113 Stanley Street
- Suite 103
- West Melbourne, Victoria 3003
- Australia
Corporate Office
- 113 Stanley Street
- Suite 103
- West Melbourne, Victoria 3003
- Australia
Acrux Timeline
Acrux Stock Performance
As of 11-Nov-2026, Acrux’s current market cap is $3.78M with 612M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.78M | 612M | 889K |
Acrux Financials Summary
As of 30-Sep-2026, Acrux has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 4,415 | 5,179 | 3,469 | 11,807 |
| Revenue | 2,912 | 770 | 3,336 | |
| EBITDA | 160 | (3,369) | (3,403) | |
| Net Income | (409) | (3,847) | (3,801) | |
| Total Assets | 4,016 | 4,719 | 5,991 | |
| Total Debt | 1,733 | 2,374 | 2,476 |
Acrux Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Acrux Comparisons
Industry
Financing
Details
Acrux Competitors (3)
One of Acrux’s 3 competitors is Pfizer, a Corporation company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer | Corporation | New York, NY | ||||
| Mint Pharmaceuticals | Corporation | Mississauga, Canada | ||||
| Amgen | Formerly PE-Backed | Thousand Oaks, CA |
Acrux Patents
Acrux Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2016904447-A0 | Topical antifungal composition and method for treatment of fungal infections | Inactive | 31-Oct-2016 | ||
| AU-2014902966-A0 | Antifungal composition | Inactive | 31-Jul-2014 | ||
| AU-2014902967-A0 | Topical composition | Inactive | 31-Jul-2014 | ||
| WO-2016015094-A1 | Topical composition | Inactive | 31-Jul-2014 | ||
| AU-2014354816-A1 | A device for dispensing and applying a liquid | Inactive | 26-Nov-2013 | A61M35/003 |
Acrux Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Acrux Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Acrux Investments (1)
Acrux’s most recent deal was a Corporate Asset Purchase with Population Council (Contraceptive Spray Intellectual Property Rights). The deal was made on 14-Feb-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Population Council (Contraceptive Spray Intellectual Property Rights) | 14-Feb-2006 | Corporate Asset Purchase | Buildings and Property |
Acrux ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Acrux FAQs
-
When was Acrux founded?
Acrux was founded in 1998.
-
Where is Acrux headquartered?
Acrux is headquartered in West Melbourne, Australia.
-
What is the size of Acrux?
Acrux has 25 total employees.
-
What industry is Acrux in?
Acrux’s primary industry is Pharmaceuticals.
-
Is Acrux a private or public company?
Acrux is a Public company.
-
What is Acrux’s stock symbol?
The ticker symbol for Acrux is ACR.
-
What is the current market cap of Acrux?
The current market capitalization of Acrux is $3.78M.
-
Who are Acrux’s competitors?
Pfizer, Mint Pharmaceuticals, and Amgen are competitors of Acrux.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
